AI as a game-changer in Life Sciences & Health- Part 1
In an era of exponential technological advancement, artificial intelligence (AI) is at the heart of the evolution of Life Sciences. From accelerating drug development to improving diagnostic accuracy and precision, AI is unlocking innovations for pharmaceutical companies that were previously unimaginable. AI’s ability to analyze massive datasets, uncover hidden patterns, and continuously learn makes it an indispensable tool for scientists, researchers and healthcare professionals. But how does this technology translate into real-world impact? In this four-part blog series, we will explore both the opportunities and challenges of AI in healthcare. In this first part, we delve into AI’s role in the discovery and development of new drugs.
Drug discovery
The identification of new molecules as potential drug targets heavily depends on efficiently analyzing large datasets. The introduction of AI has drastically accelerated drug discovery and development, offering pharmaceutical companies strategic advantages1, including:
Accelerated research: AI algorithms can analyze vast amounts of data to identify chemical compounds suitable for drug development. This includes screening databases of existing chemical compounds and synthesizing new molecules. AI enables researchers to evaluate millions of options within hours—whereas, without AI, this process would take months.
Personalized medicine: By analyzing patient data such as medical history and genetic profiles, AI enables the development of tailored therapies. These treatments are better suited to individual patients, improving both effectiveness and overall quality of life.
Early elimination of ineffective drugs: AI can predict toxicity and potential side effects of drugs in early development stages, allowing unsuccessful drugs to be ruled out quickly. This prevents the unnecessary use of human or animal test subjects, saves companies time and costs, and increases the likelihood of a positive assessment for expensive drug projects.
Drug repurposing: AI makes it possible to analyze existing drugs for new potential applications. This can be particularly valuable in crisis situations, such as pandemics, where speed and efficiency are crucial in providing effective treatments.
Virtual Trials: AI enables virtual clinical trials that simulate human or animal responses. This reduces reliance on animal testing, lowers costs, and can lead to more accurate and reliable results.
Practical use of AI in drug development
AI offers unprecedented opportunities to accelerate and improve drug discovery, but its true power lies in collaboration between various stakeholders. One example is the work of Oncode Accelerator, a public-private partnership that drives preclinical cancer research. Oncode Accelerator successfully uses AI to harmonize data from multiple sources and identify new therapies for difficult-to-treat cancers.2 This allows cancer researchers to make more efficient use of existing data, with the expectation of translating these insights into clinically relevant applications.
Another groundbreaking example of AI in drug development is AlphaFold, a technology developed by DeepMind that predicts the 3D structure of proteins with unprecedented accuracy. This has revolutionized our understanding of biology and provides pharmaceutical companies with a powerful tool to develop new drugs faster and more efficiently. AlphaFold has, for instance, contributed to accelerating research on diseases such as Alzheimer’s and certain types of cancer by offering insights into protein interactions and drug targets.3
Part 2 of this blog series will explore the applications of AI in clinical trials. Stay tuned!
References
- José Jiménez-Luna J, et al. Artificial intelligence in drug discovery: recent advances and future perspectives. Expert Opinion on Drug Discovery. 2021;16:9, 949-959.
- https://www.oncodeaccelerator.nl/our-approach
- https://www.nvon.nl/nvox/alphafold-een-revolutie-in-eiwitvoorspellingen